https://www.selleckchem.com/products/ABT-869.html
Extracapsular spread was observed in 90.2% of patients and was not a significant predictor of outcome. We found the demographics and oncologic outcomes of our cohort in the Northeast United States to be comparable with those previously reported in Australia and the Sun Belt of the United States. We noted a high rate of extracapsular spread but did not find it to be a significant predictor of recurrence or survival. Future efforts should address the impact of extracapsular spread on prognosis and adjuvant treatment decisions. We found th
Like
Comment
Share
